Currents in Pharmacy Teaching and Learning
Volume 2, Issue 1 , Pages 2-11 , January 2010

Public health matters: the role of the pharmacist and the academy

  • Ruth E. Nemire, BSPh, EdD, PharmD

      Affiliations

    • Department of Pharmacy and Health Outcomes, Touro College of Pharmacy, New York, NY
    • Corresponding Author InformationCorresponding author. Ruth E. Nemire, BSPh, EdD, PharmD, Associate Dean for Professional Education and Community Engagement, Professor Pharmacy and Health Outcomes, Touro College of Pharmacy, 2090 Adam Clayton Powell Jr. Blvd., New York, NY 10027
    • ,
  • Ceressa T. Ward, PharmD, BCPS

      Affiliations

    • Nutrition Support Team, Emory University Hospital Midtown, Atlanta, GA
    • ,
  • Karen Whalen, PharmD, BCPS, CDE

      Affiliations

    • University of Florida, Gainesville, FL
    • ,
  • John Quinn, RPh, MS

      Affiliations

    • Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD
    • ,
  • Vaiyapuri Subramaniam, PharmD, MS, FCP, FASHP, FASCP

      Affiliations

    • Department of Veterans Affairs (Central Office), Pharmacy Benefits Management SHG, Veterans Health Administration, Washington, DC
    • ,
  • Sharon K. Gershon, PharmD

      Affiliations

    • Good Clinical Practice Branch II, Division of Scientific Investigations, CDER, US Food and Drug Administration, Bethesda, MD
    • ,
  • Robin M. Zavod, PhD

      Affiliations

    • Department of Pharmaceutical Sciences, Midwestern University Chicago College of Pharmacy, Downers Grove, IL

References 

  1. Kung HC, Hoyert DL, Xu J, et al. Deaths: Final Data for 2005 (National Vital Statistics Reports). Nat Center Health Stat. 2008;56:1–121http://www.cdc.gov/nchs/data/nvsr/nvsr56/nvsr56_10.pdfAccessed on January 19, 2010
  2. Parker PM. Matter. Webster's Online Dictionary. 2004;http://www.websters-online-dictionary.org/MA/MATTER.htmlAccessed January 19, 2010
  3. Accreditation Council of Pharmacy Education. Standard No. 11 (Areas and content of curricular core. Guideline 11.3). http://www.acpe-accredit.org/standards/standards1.asp#32006;Accessed January 19, 2010
  4. Calis KA, Hutchison LC, Elliot ME, et al. Healthy People 2010: challenges, opportunities and a call for action for America's pharmacists. Pharmacotherapy. 2004;24:1241–1294
  5. Institute of Medicine. Healthcare and quality. http://www.iom.edu/Global/Topics/Quality-Patient-Safety.aspx2004;Accessed January 19, 2010
  6. American Public Health Association. The Role of the Pharmacist in Public Health. http://www.apha.org/advocacy/policy/policysearch/default.htm?id=13382009;Accessed January 19, 2010
  7. US Department of Health and Human Services. Healthy People 2010: understanding and improving health. 2nd ed.. Washington, DC: U.S. Government Printing Office; 2000;http://www.healthypeople.govAccessed January 19, 2010
  8. Babb VJ, Babb J. Pharmacist involvement in Healthy People 2010. J Am Pharm Assoc. 2003;43:56–60
  9. Institute of Medicine, Committee for the Study of the Future of Public Health, Division of Health Care Services. The future of public health. Washington, DC: National Academy Press; 1988;
  10. Association of Schools of Public Health. What is public health?. http://www.asph.org/document.cfm?page=3002009;Accessed January 19, 2010
  11. US Food and Drug Administration. CDER 2005 Report to the nation: improving public health through human drugs. Rockville, MD http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/WhatWeDo/UCM078935.pdfAccessed January 19, 2010
  12. Smith S, Cowan C, Heffler S, et al. National Health Accounts Team National health spending in 2004: recent slowdown led by prescription drug spending. Health Aff. 2006;25:186–196
  13. Food and Drug Administration. CDER New Molecular Entity (NME) Drug and New Biologic Approvals in Calendar Year 2006. http://www.fda.gov/cder/rdmt/InternetNME08.pdfAccessed January 19, 2010
  14. Food and Drug Administration. New Drug Application and Biologic Application License Application (BLA) Efficacy Supplements. http://www.fda.gov/cder/rdmt/ESCY08.pdf2008;Accessed January 19, 2010
  15. Centers for Medicare and Medicaid Services. National Health Expenditure Data. http://www.cms.hhs.gov/NationalHealthExpendData/01_Overview.asp2006;Accessed January 19, 2010
  16. Borger C, Smith S, Truffer C, et al. Health spending projections through 2015: changes on the horizon. Health Aff. 2006;25:w61–w73
  17. In:  Kohn LT,  Corrigan JM,  Donaldson MS editor. To err is human: building a safer health system. Committee on Quality of Health Care in America, Institute of Medicine. Washington, DC: National Academy Press; 2000;http://www.nap.edu/catalog.php?record_id=9728Accessed January 19, 2010
  18. Neergaard L. Report drug injuries more than 1.5 M. http://www.sfgate.com/cgi-bin/article.cgi?f=/n/a/2006/07/20/national/w142049D97.DTL&type=politics2006;Accessed January 19, 2010
  19. Ross B. Pharmacy errors: unreported epidemic?. 20/20 (aired March 30, 2007) http://abcnews.go.com/Video/playerIndex?id=3003647Accessed January 19, 2010
  20. Lundkvist J, Jonsson B. Pharmacoeconomics of adverse drug reactions. Fundam Clin Pharmacol. 2004;18:275–280
  21. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192–199
  22. Department of Health and Human Services, Centers for Medicare and Medicaid Services. 42 CFR Parts 400, 403, 411, 417, and 423 Medicare program; Medicare prescription drug benefit; final rule. Federal Register. 2005;http://edocket.access.gpo.gov/2005/pdf/05-1321.pdfAccessed January 19, 2010
  23. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–543
  24. Schumock GT, Meek PD, Ploetz PA, et al. Economic evaluations of clinical pharmacy services—1988-1995. Pharmacotherapy. 1996;16:1188–1208
  25. Carmichael JM, Alvarez A, Chaput R, et al. Establishment and outcomes of a model primary care pharmacy service system. Am J Health Syst Pharm. 2004;61:472–482
  26. National Community Pharmacists Association. What you need to know about part D. http://www.ncpanet.org/ccrx/medicarepartd/index.phpAccessed January 19, 2010
  27. Medical Reserve Corps of Virginia. Home page. http://www.vdh.state.va.us/mrc/2008;Accessed January 19, 2010
  28. New Jersey Medical Reserve Corps. Home page. http://www.njmrc.nj.gov/hcpr/index.html#2004;Accessed January 19, 2010
  29. Grabenstein JD. Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes and hospitals. Vaccine. 1998;16:1705–1710
  30. Soon JA, Levine M, Ensom MH, et al. The developing role of pharmacists in patient access to emergency contraception. Dis Manag Health Outcomes. 2002;10:601–611
  31. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management. Arch Intern Med. 2002;162:1149–1155
  32. Ives TJ, Paavola FG, Der Marderosian AH. Pharmacists and public health. In: Remington's Pharmaceutical Sciences. 20th ed.. Baltimore, MD: Williams & Wilkins; 2001;
  33. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149–159
  34. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173–184
  35. Downing D. Pharmacist prescribing of emergency contraception: the Washington state experience. In: APhA Special Report Emergency Contraception: The Pharmacist's Role. Washington, DC: American Pharmacists Association; 2004;
  36. US Food and Drug Administration. FDA approves over-the-counter access for Plan B for women 18 and older prescription remains required for those 17 and under. http://www.fda.gov/bbs/topics/NEWS/2006/NEW01436.html2006;Accessed January 19, 2010
  37. Anderson RN, Smith BL. Deaths: leading causes for 2002 (National vital statistics reports). Nat Center Health Stat. 2005;53(17):1–90http://www.cdc.gov/nchs/data/nvsr/nvsr53/nvsr53_17.pdfAccessed January 19, 2010
  38. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–2572
  39. Thorn T, Haase N, Rosamond W, et al. Heart disease and stroke statistics 2006 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2006;13:e85–e151
  40. Carter BL, Barnette DJ, Chrischilles E, et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997;17:1274–1285
  41. McKenney JM, Slining JM, Henderson HR, et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973;48:1104–1111
  42. Park JJ, Kelly P, Carter BL, et al. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc. 1996;36:443–451
  43. Zillich AJ, Sutherland JM, Kumbera PA, et al. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME Study). J Gen Intern Med. 2005;20:1091–1096
  44. Centers for Disease and Control Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2006;55:1–42
  45. Centers for Disease and Control Prevention. National, state, and urban area vaccination coverage among children aged 19-35 months—United States, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:988–993
  46. Immunization Action Coalition. States authorizing pharmacists to vaccinate. http://www.immunize.org/laws/pharm.htm2008;Accessed January 19, 2010
  47. American Society of Health-System Pharmacists, Council on Professional Affairs. ASHP guidelines on the pharmacist's role in immunization. Am J Health Syst Pharm. 2003;60:1371–1377
  48. Steyer TE, Ragucci KR, Pearson WS, et al. The role of pharmacists in the delivery of influenza vaccinations. Vaccine. 2004;22:1001–1006
  49. Cerulli J, Zeolla MM. Impact and feasibility of a community pharmacy bone mineral density screening and education program. J Am Pharm Assoc. 2004;44:161–167
  50. Elliott ME, Meek PD, Kanous NL, et al. Pharmacy-based bone mass measurement to assess osteoporosis risk. Ann Pharmacother. 2002;36:571–577
  51. Goode JK, Swiger K, Bluml BM. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: osteoporosis. J Am Pharm Assoc. 2004;44:152–160
  52. Center for Disease and Control Prevention. Cigarette smoking among adults—United States, 2004. MMWR Morb Mortal Wkly Rep. 2005;54:1121–1124
  53. Kennedy DT, Small RE. Development and implementation of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42:83–92
  54. Kennedy DT, Giles JT, Chang ZG, et al. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc. 2002;42:51–56
  55. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004;99:29–38
  56. Mika VS, Kelly PJ, Price MA, et al. The ABCs of health literacy. Fam Community Health. 2005;28:351–357
  57. Barner JC, Brown CM, Shepherd MD, et al. Provision of pharmacy services in community health centers and migrant health centers. J Am Pharm Assoc. 2002;42:713–722
  58. Dent LA, Stratton TP, Cochran GA. Establishing an on-site pharmacy in a community health center to help indigent patients access medications and improve care. J Am Pharm Assoc. 2002;42:497–507
  59. Lamsam GD, Stone BA, Rumsey T, et al. Pharmaceutical services for a homeless population. Am J Health Syst Pharm. 1996;53:1426–1430
  60. Spangler D. VA electronic rx records aid Katrina relief response. US Medicine. 2005;81:Article 1202
  61. Fitzhugh M. Plagues and politics—the story of the United States Public Health Service. New York: Basic Books; 1989;
  62. US Public Health Service. The history of the commissioned corps. http://www.usphs.gov/AboutUs/history.aspx2008;Accessed January 19, 2010
  63. Management Information System. http://dcp.psc.gov/rpt_agency_by_category.aspAccessed January 19, 2010
  64. American Society of Health-System Pharmacists. Public health service plans to expand force, streamline deployments. http://www.ashp.org/import/news/HealthSystemPharmacyNews/newsarticle.aspx?id=20922009;Accessed January 19, 2010
  65. Medical Reserve Corps. Home page. http://www.medicalreservecorps.gov/HomePage2009;Accessed January 19, 2010
  66. Teeter DS. Disaster preparedness and pharmacy: an important partnership. US Pharmacist. 2004;29:1–7
  67. Young D. Omaha pharmacist helps city prepare for disasters. Am J Health Syst Pharm. 2004;61:756–758
  68. Young D. Iowa pharmacists dispense from Strategic National Stockpile during drill. Am J Health Syst Pharm. 2003;60:1304–1305
  69. Thompson CA. Illinois hospital pharmacies check their emergency preparedness. Am J Health Syst Pharm. 2003;60:1299–1300
  70. Centers for Disease and Control Prevention. Strategic national stockpile. http://www.bt.cdc.gov/stockpile/2008;Accessed January 19, 2010
  71. Accreditation Council for Pharmacy Education. Standard no. 10 (Professional competencies and outcome expectations). http://www.acpe-accredit.org/standards/standards1.asp#32006;Accessed January 19, 2010
  72. CAPE Advisory Panel on Educational Outcomes. Professional and general abilities based outcomes (American Association of Colleges of Pharmacy). http://www.aacp.org1998;Accessed January 19, 2010
  73. Nemire R, Meier S. Educating students for practice: educational outcomes and community experience. Am J Pharm Educ. 2006;70:Article 20
  74. Fincham JE. Public health pharmacy and the prevention education resource center. Am J Pharm Educ. 2007;71:Article 104
  75. Moore SR. The myth of the public health pharmacist in the U.S.A.. R Soc Health J. 1981;101:155–157
  76. Anderson AS, Goode JV. Engaging students in wellness and disease prevention services. Am J Pharm Educ. 2006;70:Article 40
  77. Ward CT, Nemire RE, Daniel KP. The development and assessment of a medical mission elective course. Am J Pharm Educ. 2005;69:Article 50
  78. Nemire RE, Ward CT, Daniel KL. Assessing the impact of pharmacy services during a medical mission. 2nd American Colleges of Clinical Pharmacy–European Society of Clinical Pharmacy (ACCP-ESCP) Joint Meeting. Paris, France. April 2004.
  79. American Public Health Association. APHA policy 8024: the role of the pharmacist in public health. Am J Public Health. 1981;71:213–216
  80. Health Resources and Services Administration. Public health. http://bhpr.hrsa.gov/grants/public.htmAccessed January 19, 2010

 No official support or endorsement of this article by the Food and Drug Administration is intended or should be inferred. The views presented in this article do not necessarily reflect those of the Food and Drug Administration.

PII: S1877-1297(09)00055-0

doi: 10.1016/j.cptl.2009.12.001

Currents in Pharmacy Teaching and Learning
Volume 2, Issue 1 , Pages 2-11 , January 2010

Article Tools